These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8608356)

  • 1. Prognostic value of quantitative measurement of rheumatoid factor in early rheumatoid arthritis.
    Paimela L; Palosuo T; Leirisalo-Repo M; Helve T; Aho K
    Br J Rheumatol; 1995 Dec; 34(12):1146-50. PubMed ID: 8608356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rheumatoid factor by laser nephelometry and Waaler-Rose assay: prognostic value in patients with recent-onset rheumatoid arthritis.
    Nikolaisen C; Rekvig OP; Nossent HC
    Scand J Rheumatol; 2005; 34(4):269-76. PubMed ID: 16195159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of tobacco smoking and rheumatoid factor seropositivity on disease activity and joint damage in early rheumatoid arthritis.
    Manfredsdottir VF; Vikingsdottir T; Jonsson T; Geirsson AJ; Kjartansson O; Heimisdottir M; Sigurdardottir SL; Valdimarsson H; Vikingsson A
    Rheumatology (Oxford); 2006 Jun; 45(6):734-40. PubMed ID: 16403829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgM, IgA, and IgG rheumatoid factors in early rheumatoid arthritis predictive of radiological progression?
    van Leeuwen MA; Westra J; van Riel PL; Limburg PC; van Rijswijk MH
    Scand J Rheumatol; 1995; 24(3):146-53. PubMed ID: 7777825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of proto-oncogene survivin predicts Joint destruction and persistent disease activity in early rheumatoid arthritis.
    Svensson B; Hafström I; Forslind K; Albertsson K; Tarkowski A; Bokarewa M
    Ann Med; 2010; 42(1):45-54. PubMed ID: 20092399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum matrix metalloproteinase-3 as predictor of joint destruction in rheumatoid arthritis, treated with non-biological disease modifying anti-rheumatic drugs.
    Mamehara A; Sugimoto T; Sugiyama D; Morinobu S; Tsuji G; Kawano S; Morinobu A; Kumagai S
    Kobe J Med Sci; 2010 Sep; 56(3):E98-107. PubMed ID: 21063156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reductions in Radiographic Progression in Early Rheumatoid Arthritis Over Twenty-Five Years: Changing Contribution From Rheumatoid Factor in Two Multicenter UK Inception Cohorts.
    Carpenter L; Norton S; Nikiphorou E; Jayakumar K; McWilliams DF; Rennie KL; Dixey J; Kiely P; Walsh DA; Young A;
    Arthritis Care Res (Hoboken); 2017 Dec; 69(12):1809-1817. PubMed ID: 28217885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease.
    Machold KP; Stamm TA; Nell VP; Pflugbeil S; Aletaha D; Steiner G; Uffmann M; Smolen JS
    Rheumatology (Oxford); 2007 Feb; 46(2):342-9. PubMed ID: 16899498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic markers of radiographic progression in early rheumatoid arthritis.
    Goronzy JJ; Matteson EL; Fulbright JW; Warrington KJ; Chang-Miller A; Hunder GG; Mason TG; Nelson AM; Valente RM; Crowson CS; Erlich HA; Reynolds RL; Swee RG; O'Fallon WM; Weyand CM
    Arthritis Rheum; 2004 Jan; 50(1):43-54. PubMed ID: 14730598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rheumatoid factor determines structural progression of rheumatoid arthritis dependent and independent of disease activity.
    Aletaha D; Alasti F; Smolen JS
    Ann Rheum Dis; 2013 Jun; 72(6):875-80. PubMed ID: 22798565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis.
    Nell VP; Machold KP; Stamm TA; Eberl G; Heinzl H; Uffmann M; Smolen JS; Steiner G
    Ann Rheum Dis; 2005 Dec; 64(12):1731-6. PubMed ID: 15878904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of radiographic joint damage in patients with early rheumatoid arthritis.
    Jansen LM; van der Horst-Bruinsma IE; van Schaardenburg D; Bezemer PD; Dijkmans BA
    Ann Rheum Dis; 2001 Oct; 60(10):924-7. PubMed ID: 11557647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis.
    Kuru O; Bilgici A; Birinci A; Ulusoy H; Durupinar B
    Bratisl Lek Listy; 2009; 110(10):650-4. PubMed ID: 20017459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage.
    Meyer O; Labarre C; Dougados M; Goupille P; Cantagrel A; Dubois A; Nicaise-Roland P; Sibilia J; Combe B
    Ann Rheum Dis; 2003 Feb; 62(2):120-6. PubMed ID: 12525380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with "sawtooth" strategy.
    Möttönen T; Paimela L; Leirisalo-Repo M; Kautiainen H; Ilonen J; Hannonen P
    Ann Rheum Dis; 1998 Sep; 57(9):533-9. PubMed ID: 9849312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies.
    de Vries-Bouwstra JK; Goekoop-Ruiterman YP; Verpoort KN; Schreuder GM; Ewals JA; Terwiel JP; Ronday HK; Kerstens PJ; Toes RE; de Vries RR; Breedveld FC; Dijkmans BA; Huizinga TW; Allaart CF
    Arthritis Rheum; 2008 May; 58(5):1293-8. PubMed ID: 18438829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study.
    Syversen SW; Gaarder PI; Goll GL; Ødegård S; Haavardsholm EA; Mowinckel P; van der Heijde D; Landewé R; Kvien TK
    Ann Rheum Dis; 2008 Feb; 67(2):212-7. PubMed ID: 17526555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiological progression in early rheumatoid arthritis after DMARDS: a one-year follow-up study in a clinical setting.
    Sanmarti R; Gomez A; Ercilla G; Gratacos J; Larrosa M; Suris X; Vinas O; Salvador G; Munoz-Gomez J; Canete JD
    Rheumatology (Oxford); 2003 Sep; 42(9):1044-9. PubMed ID: 12730518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-MCV antibodies predict radiographic progression in Greek patients with very early (<3 months duration) rheumatoid arthritis.
    Barouta G; Katsiari CG; Alexiou I; Liaskos C; Varna A; Bogdanos DP; Germenis AE; Sakkas LI
    Clin Rheumatol; 2017 Apr; 36(4):885-894. PubMed ID: 27943044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.